What's Going On With Marvell Technology Stock Wednesday?
Marvell Technology stock surged over 9% Wednesday amid an AI-driven tech rally. See key support levels, analyst targets, and price action.
Stocks · News reference
Marvel Biosciences Announces Expanded Investor Awareness Initiatives
Marvel Biosciences entered into marketing services agreements with Outside The Box Capital Inc. and Investing News Network to increase awareness of its drug development platform.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Regal Rexnord is 'Worth So Much More,' Don't Overlook Churchill Downs: Jim Cramer
Cramer favors Regal Rexnord and Churchill Downs, is cautious on Marvell, dismissive of Snap and unaware of Perimeter.
Marvell's $115 Billion Lumentum Deal Faces 50-50 Odds: Report
Can Marvell complete its $115 billion Lumentum takeover? Merger specialists see only a 50% chance of success.
Why Marvell Technology Stock Fell Hard in October
Marvell Technology's stock plunged 25.6% in October as investors fled AI stocks amid concerns about excessive tech spending on data center infrastructure. The decline accelerated after Bloomberg reported Marvell's plan to acquire optical component maker Lumentum for $115 billion in an all-stock deal, raising shareholder dilution concerns. Despite strong fiscal guidance announced earlier in the month, broader AI sector skepticism and rising inflation fears dominated market sentiment.
Why Is Marvell Stock Surging on Monday?
Marvell Technology Inc. (NASDAQ: MRVL) stock rises Monday as broad market indexes rebounded after semiconductor losses last week.
Jensen Huang's Reported Affair With Suspected Chinese Spy Pushes Nvidia Stock to Most Oversold Level Since 2019
Nvidia stock hits its most oversold level since 2019 as a board probe into Jensen Huang's reported affair splits NVDA from a rallying chip sector.